Transcatheter heart valves for transcatheter aortic valve implantation to treat aortic stenosis: late-stage assessment

Update post-resolution period. NICE has a resolution process that acts as a final quality-assurance step to ensure that NICE acts fairly, follows its own processes, and produces clear, accurate guidance. Please see section 7.2 in NICE's health technology manual for more detail on this process. A resolution panel has been held. A resolution request on breach of process was upheld regarding the wording of the recommendation. The panel recommended reconvening committee to reconsider the relevance of NG208 to cross-reference cost-effectiveness thresholds and the determination of value for money in this LSA. The panel also concluded that the reconvened committee should review the approach to searching for and selecting evidence in this LSA. We are currently looking at the schedule and will be in touch soon regarding the date of this committee, and key steps leading up to it.